Clinical Trial Update: Single Ascending Dose Study of RBP-6000 [Phase 1]

View source ↗

Summary

Phase 1 single ascending dose study of RBP-6000 for opioid use disorder has completed, providing early safety and pharmacokinetic data. The update reflects comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• RBP-6000 (buprenorphine)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Use Disorder | Phase 1 | Status: COMPLETED